Latest S-1 registration statements

Sonnet BioTherapeutics is registering for resale 127,500 shares of common stock and 2,303,825 shares issuable upon exercise of warrants, following recent private placements.

Nexalin Technology is filing an amendment to its Form S-1 registration statement to allow selling stockholders to resell up to 2,798,613 shares of common stock.

Enveric Biosciences has filed an amendment to its S-1 registration statement, primarily to include updated exhibits related to its financial and legal agreements.

Hashdex Nasdaq Crypto Index US ETF establishes a cash custody agreement with U.S. Bank National Association for safekeeping of fund assets.

Klotho Neurosciences is registering for resale up to 43.7 million shares of common stock, including shares issuable upon conversion of notes and exercise of warrants, by existing shareholders.

High Wire Networks, Inc. is seeking to raise capital through a public offering of 750,000 shares and register the resale of 583,296 shares by existing stockholders.

Enveric Biosciences is seeking to raise capital through an offering of common stock, pre-funded warrants, and accompanying Series A and Series B warrants.

Maze Therapeutics, a clinical-stage biopharmaceutical company, has filed for an initial public offering to advance its pipeline of precision medicines for renal, cardiovascular, and metabolic diseases.

Solidion Technology, Inc. has filed an amendment to its Form S-1 registration statement, potentially allowing existing securityholders to resell up to 293,457,926 shares of common stock.

K&F Growth Acquisition Corp. II has formalized its share rights agreement with Continental Stock Transfer & Trust Company in preparation for its initial public offering.

Scienture Holdings has filed an amendment to its S-1 registration statement to allow for the resale of up to 4.3 million shares of common stock by certain selling stockholders.

Beta Bionics files a registration statement to increase the number of shares offered in its public offering by 2,300,000, including an underwriter option, following the effectiveness of its initial S-1 registration.

Artius II Acquisition Inc., a blank check company, is set to launch a $200 million IPO targeting technology-enabled businesses.

Permex Petroleum intends to register for resale up to 4,699,394 common shares issuable upon conversion of debentures and exercise of purchase warrants.

Wheeler Real Estate Investment Trust files an S-11 registration statement to cover the issuance of common stock upon redemption and conversion of its Series D Preferred Stock.

Mullen Automotive is registering for resale up to 50 million shares of common stock by selling stockholders, primarily derived from convertible notes and warrants, as the company navigates a complex financial landscape.

Apimeds Pharmaceuticals US, Inc. is seeking to list its common stock on the NYSE American through a $14.4 million initial public offering.

Cellectar Biosciences is registering for resale up to 19,221,348 shares of its common stock by selling stockholders after a warrant inducement transaction.

Momentus Inc. is offering up to 1,500,000 shares of common stock along with pre-funded and common stock purchase warrants in a best efforts offering.

Cartesian Growth Corporation III, a newly formed blank check company, has filed an S-1 registration statement for a $200 million initial public offering, aiming to pursue a business combination with a high-growth business possessing transnational operations or potential.

Moleculin Biotech is launching a public offering of common stock and warrants to raise up to $8 million for clinical development of its cancer and antiviral drug portfolio.

Kairos Pharma has filed a registration statement for the resale of 6.4 million shares of common stock, including shares underlying warrants issued in a recent private placement.

Northann Corp. has filed an amended S-1 registration statement for the resale of up to 30,084,400 shares of common stock by selling stockholders.

Firefly Neuroscience, Inc. files an amendment to its registration statement, detailing the offering of over 2.5 million shares of common stock and underlying warrants.

Vivos Therapeutics has filed an amendment to its S-1 registration statement, primarily to remove reliance on previously incorporated information, relating to the potential resale of common stock and warrants.

Odysight.ai Inc. has filed an amendment to its S-1 registration statement, detailing a proposed public offering of its common stock and its application to list on the Nasdaq Capital Market.

Functional Brands Inc., formerly HT Naturals Inc., files an amendment to its S-1 registration statement, outlining details for its initial public offering and a name change.

Winchester Bancorp, Inc., the proposed holding company for Winchester Savings Bank, has filed an amendment to its S-1 registration statement for its mutual holding company reorganization, offering up to 4,061,964 shares of common stock to eligible depositors and the general public.

Gesher Acquisition Corp. II, a blank check company, aims to raise $125 million in an initial public offering to pursue a business combination with a target in Israel, focusing on technology businesses with international operations.

TriUnity Business Services Limited filed an S-1/A registration statement to offer 8,000,000 shares of common stock at $0.015 per share, aiming to raise up to $120,000 for operational expansion.